DK156592A - Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin - Google Patents

Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin Download PDF

Info

Publication number
DK156592A
DK156592A DK156592A DK156592A DK156592A DK 156592 A DK156592 A DK 156592A DK 156592 A DK156592 A DK 156592A DK 156592 A DK156592 A DK 156592A DK 156592 A DK156592 A DK 156592A
Authority
DK
Denmark
Prior art keywords
relaxin
human
chains
preeprorelaxin
prorelaxin
Prior art date
Application number
DK156592A
Other languages
English (en)
Other versions
DK156592D0 (da
DK171683B1 (da
Inventor
Peter John Hudson
John Shine
Hugh David Niall
Geoffrey William Tregear
Original Assignee
Florey Howard Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florey Howard Inst filed Critical Florey Howard Inst
Publication of DK156592D0 publication Critical patent/DK156592D0/da
Publication of DK156592A publication Critical patent/DK156592A/da
Application granted granted Critical
Publication of DK171683B1 publication Critical patent/DK171683B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK156592A 1982-08-12 1992-12-28 Analogifremgangsmåde til fremstilling af human-H1-relaxinanalog DK171683B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPF535282 1982-08-12
AUPF535282 1982-08-12

Publications (3)

Publication Number Publication Date
DK156592D0 DK156592D0 (da) 1992-12-28
DK156592A true DK156592A (da) 1992-12-28
DK171683B1 DK171683B1 (da) 1997-03-10

Family

ID=3769689

Family Applications (2)

Application Number Title Priority Date Filing Date
DK366483A DK171827B1 (da) 1982-08-12 1983-08-11 Dobbeltstrenget DNA-fragment, der koder for human-H1-præprorelaxin, human-H1-prorelaxin eller A- og B-kæderne i human-H1-relaxin, samt DNA-transfervektor, der indeholder en cDNA-deoxynukleotidsekvens, som svarer til et sådant DNA-fragment, celle transformeret med en sådan DNA-transfervektor, og fremgangsmåde til fremstilling af human-H1-prorelaxin eller -H1-relaxin ved dyrkning af en sådan celle
DK156592A DK171683B1 (da) 1982-08-12 1992-12-28 Analogifremgangsmåde til fremstilling af human-H1-relaxinanalog

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK366483A DK171827B1 (da) 1982-08-12 1983-08-11 Dobbeltstrenget DNA-fragment, der koder for human-H1-præprorelaxin, human-H1-prorelaxin eller A- og B-kæderne i human-H1-relaxin, samt DNA-transfervektor, der indeholder en cDNA-deoxynukleotidsekvens, som svarer til et sådant DNA-fragment, celle transformeret med en sådan DNA-transfervektor, og fremgangsmåde til fremstilling af human-H1-prorelaxin eller -H1-relaxin ved dyrkning af en sådan celle

Country Status (14)

Country Link
US (1) US4871670A (da)
EP (2) EP0101309B1 (da)
JP (3) JP2537477B2 (da)
KR (1) KR930003515B1 (da)
AT (1) ATE78042T1 (da)
CA (1) CA1340542C (da)
DE (1) DE3382117D1 (da)
DK (2) DK171827B1 (da)
ES (5) ES8603579A1 (da)
HU (1) HU197350B (da)
IE (1) IE58682B1 (da)
IL (1) IL69469A (da)
NZ (1) NZ205241A (da)
ZA (1) ZA835963B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320953A (en) * 1982-08-12 1994-06-14 Howard Florey Institute Of Experimental Physiology And Medicine Process for synthesizing human H1-prorelaxin, H1-relaxin and fusion proteins thereof
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
NZ206534A (en) * 1982-12-13 1988-05-30 Florey Howard Inst Molecular cloning and characterisation of gene sequence coding for human relaxin
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
WO1989007945A1 (en) * 1988-02-26 1989-09-08 Genentech, Inc. Human relaxin formulation
CA2051375C (en) * 1989-05-04 2000-09-12 Dennis J. Henner Process and compositions for the isolation of human relaxin
US5089419A (en) * 1989-08-07 1992-02-18 International Canine Genetics Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
US6348327B1 (en) 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
ATE241012T1 (de) * 1993-06-21 2003-06-15 Genentech Inc Verfahren zur herstellung von humanen relaxin
US5911997A (en) * 1995-06-07 1999-06-15 Connetics Corporation Relaxin-like factor and methods and uses thereof
US20070021360A1 (en) * 2001-04-24 2007-01-25 Nyce Jonathan W Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase
US20030088884A1 (en) * 2001-08-17 2003-05-08 Hsu Sheau Yu Mammalian relaxin receptors
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
AU2005247332A1 (en) * 2004-04-30 2005-12-08 Corthera, Inc. Methods and compositions for control of fetal growth via modulation of relaxin
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
US8389475B2 (en) 2009-08-10 2013-03-05 The Board Of Trustees Of The Leland Stanford Junior University Relaxin analogs
MX346786B (es) 2010-08-17 2017-03-31 Ambrx Inc Polipeptidos de relaxina modificados y sus usos.
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
WO2015073727A1 (en) 2013-11-13 2015-05-21 Aequus Biopharma, Inc. Engineered glycoproteins and uses thereof
EP2946788A1 (en) 2014-05-23 2015-11-25 Immundiagnostik AG Method and composition for treating heart failure with preserved ejection fraction
MA45051A (fr) 2016-05-18 2019-03-27 Modernatx Inc Polynucléotides codant la relaxine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267101A (en) * 1980-02-01 1981-05-12 Serono Laboratories Inc. Process for obtaining human relaxin from fetal membranes
IE55479B1 (en) * 1982-02-12 1990-09-26 Florey Howard Inst Molecular cloning and characterization of the gene sequence coding for porcine relaxin
NZ206534A (en) * 1982-12-13 1988-05-30 Florey Howard Inst Molecular cloning and characterisation of gene sequence coding for human relaxin

Also Published As

Publication number Publication date
CA1340542C (en) 1999-05-18
KR840005739A (ko) 1984-11-16
IL69469A (en) 1991-06-10
ES8801676A1 (es) 1988-02-16
EP0287820A1 (en) 1988-10-26
ES557506A0 (es) 1988-02-16
ES8802160A1 (es) 1988-04-01
DE3382117D1 (de) 1991-02-21
EP0101309B1 (en) 1991-01-16
HU197350B (en) 1989-03-28
IE831909L (en) 1984-02-12
IE58682B1 (en) 1993-11-03
JPS5985292A (ja) 1984-05-17
DK156592D0 (da) 1992-12-28
ES540886A0 (es) 1988-04-01
JPH07215998A (ja) 1995-08-15
ATE78042T1 (de) 1992-07-15
EP0101309A2 (en) 1984-02-22
DK366483D0 (da) 1983-08-11
EP0101309A3 (en) 1984-12-27
JP2892596B2 (ja) 1999-05-17
DK171827B1 (da) 1997-06-23
ES557505A0 (es) 1988-02-16
DK366483A (da) 1984-02-13
EP0287820B1 (en) 1992-07-08
KR930003515B1 (ko) 1993-05-01
JP2670001B2 (ja) 1997-10-29
JPH0690780A (ja) 1994-04-05
ES524885A0 (es) 1985-12-16
ZA835963B (en) 1984-04-25
IL69469A0 (en) 1983-11-30
ES8603579A1 (es) 1985-12-16
US4871670A (en) 1989-10-03
JP2537477B2 (ja) 1996-09-25
DK171683B1 (da) 1997-03-10
ES8801671A1 (es) 1988-02-16
ES8802394A1 (es) 1988-05-16
ES550943A0 (es) 1988-05-16
NZ205241A (en) 1991-01-29

Similar Documents

Publication Publication Date Title
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
DK143492A (da) Human-h2-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet
NO821111L (no) Radioaktivt merkede peptider
CY1105597T1 (el) Ανοσοθεραπευτικες μεθοδοι χρησιμοποιωντας επιτοπους των wt-1 και gata-1
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
DK262986A (da) Peptidmateriale med thymushumoral aktivitet
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
FI942392A0 (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
ATE112290T1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.
NO893572D0 (no) Lunge-overflateaktivt protein og beslektet polypeptid.
ATE98990T1 (de) Menschlicher prourokinase aehnliches polypeptid.

Legal Events

Date Code Title Description
A0 Application filed
PUP Patent expired
PUP Patent expired